{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:50:09Z","timestamp":1790211009419,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/igc.0b013e31829ea779","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T08:26:26Z","timestamp":1373531186000},"page":"1191-1197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["MicroRNA-199a-3p Regulates Endometrial Cancer Cell Proliferation by Targeting Mammalian Target of Rapamycin (mTOR)"],"prefix":"10.1016","volume":"23","author":[{"given":"Dong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-ni","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31829ea779_bb0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0010","first-page":"3","article-title":"Epidemiology and risk factors of endometrial cancer","volume":"27","author":"Qie","year":"2011","journal-title":"Chinese Journal of Practical Gynecology and Obstetrics."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0015","doi-asserted-by":"crossref","first-page":"vi35","DOI":"10.1093\/annonc\/mdr374","article-title":"Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Colombo","year":"2011","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat Rev Cancer."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/epi.12.13","article-title":"Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice","volume":"4","author":"Banno","year":"2012","journal-title":"Epigenomics."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1261\/rna.2146903","article-title":"New microRNAs from mouse and human","volume":"9","author":"Lagos-Quintana","year":"2003","journal-title":"RNA."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0040","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.3390\/ijms13078449","article-title":"Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a","volume":"13","author":"Gu","year":"2012","journal-title":"Int J Mol Sci."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1470-2045(11)70012-2","article-title":"Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections","volume":"12","author":"Marchini","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0050","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1242\/jcs.077529","article-title":"MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2","volume":"124","author":"Shatseva","year":"2011","journal-title":"J Cell Sci."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0055","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1158\/1535-7163.MCT-11-0096","article-title":"MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration","volume":"10","author":"Duan","year":"2011","journal-title":"Mol Cancer Ther."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/1078-0432.CCR-07-0523","article-title":"Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival","volume":"14","author":"Jiang","year":"2008","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0065","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","article-title":"Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice","volume":"68","author":"Daikoku","year":"2008","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GRF.0b013e3182185baa","article-title":"Revised FIGO staging system for endometrial cancer","volume":"54","author":"Lewin","year":"2011","journal-title":"Clin Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0075","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1158\/0008-5472.CAN-10-0145","article-title":"MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells","volume":"70","author":"Fornari","year":"2010","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0080","doi-asserted-by":"crossref","first-page":"376Y381","DOI":"10.1038\/nature11739","article-title":"Functional screening identif ies miRNAs inducing cardiac regeneration","volume":"492","author":"Eulalio","year":"2012","journal-title":"Nature."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0085","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-12-0662","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer","volume":"18","author":"Slomovitz","year":"2012","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0090","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1742-4658.2012.08589.x","article-title":"MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells","volume":"279","author":"Cheng","year":"2012","journal-title":"FEBS J."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0095","doi-asserted-by":"crossref","first-page":"18158","DOI":"10.1074\/jbc.M800186200","article-title":"MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2)","volume":"283","author":"Kim","year":"2008","journal-title":"J Biol Chem."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0100","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1248\/bpb.33.1822","article-title":"miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer","volume":"33","author":"Song","year":"2010","journal-title":"Biol Pharm Bull."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0105","first-page":"3765","article-title":"Cyclooxygenase-2 expression correlates with apoptosis and angiogenesis in endometrial cancer tissue","volume":"27","author":"Ohno","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0110","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.2174\/092986710794182999","article-title":"PI3K\/AKT\/mTOR inhibitors in ovarian cancer","volume":"17","author":"Mazzoletti","year":"2010","journal-title":"Curr Med Chem."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejogrb.2010.07.038","article-title":"Clinical significance of pmTOR expression in endometrioid endometrial carcinoma","volume":"153","author":"Choi","year":"2010","journal-title":"EurJ Obstet Gynecol Reprod Biol."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0120","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/ijc.24837","article-title":"Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis","volume":"126","author":"Shafer","year":"2010","journal-title":"Int J Cancer."},{"key":"10.1097\/IGC.0b013e31829ea779_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/1471-2407-12-369","article-title":"Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma","volume":"12","author":"Torres","year":"2012","journal-title":"BMC Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24019492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24019492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e31829ea779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:17Z","timestamp":1753233197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24019492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1048891X24019492"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31829ea779","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-199a-3p Regulates Endometrial Cancer Cell Proliferation by Targeting Mammalian Target of Rapamycin (mTOR)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31829ea779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}